Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 25

1.

Upward migration of a ureteric stone in a military trainer: a case report.

Fallatah M, Tahaineh S, Abu Mughli R, Fallatah SM.

Res Rep Urol. 2017 Jan 19;9:15-17. doi: 10.2147/RRU.S124200. eCollection 2017.

2.

Mucin-1 Increases Renal TRPV5 Activity In Vitro, and Urinary Level Associates with Calcium Nephrolithiasis in Patients.

Nie M, Bal MS, Yang Z, Liu J, Rivera C, Wenzel A, Beck BB, Sakhaee K, Marciano DK, Wolf MT.

J Am Soc Nephrol. 2016 Nov;27(11):3447-3458. Epub 2016 Apr 1.

3.

The morphological and immunohistochemical spectrum of gastric biopsies of patients with absorptive hypercalciuria.

Declich P, Belloni J, Tavani E, Omazzi B, Bellone S, Bortoli A, Arena I, Devani M.

BMJ Open Gastroenterol. 2015 Feb 6;1(1):e000004. doi: 10.1136/bmjgast-2014-000004. eCollection 2014.

4.

Vascular Calcification and Stone Disease: A New Look towards the Mechanism.

Yiu AJ, Callaghan D, Sultana R, Bandyopadhyay BC.

J Cardiovasc Dev Dis. 2015;2(3):141-164.

5.

Modeling hypercalciuria in the genetic hypercalciuric stone-forming rat.

Frick KK, Krieger NS, Bushinsky DA.

Curr Opin Nephrol Hypertens. 2015 Jul;24(4):336-44. doi: 10.1097/MNH.0000000000000130. Review.

6.

Klotho up-regulates renal calcium channel transient receptor potential vanilloid 5 (TRPV5) by intra- and extracellular N-glycosylation-dependent mechanisms.

Wolf MT, An SW, Nie M, Bal MS, Huang CL.

J Biol Chem. 2014 Dec 26;289(52):35849-57. doi: 10.1074/jbc.M114.616649. Epub 2014 Nov 5.

7.

Persistence of 1,25D-induced hypercalciuria in alendronate-treated genetic hypercalciuric stone-forming rats fed a low-calcium diet.

Frick KK, Asplin JR, Culbertson CD, Granja I, Krieger NS, Bushinsky DA.

Am J Physiol Renal Physiol. 2014 May 1;306(9):F1081-7. doi: 10.1152/ajprenal.00680.2013. Epub 2014 Feb 26.

8.

1,25(OH)ā‚‚Dā‚ƒ induces a mineralization defect and loss of bone mineral density in genetic hypercalciuric stone-forming rats.

Ng AH, Frick KK, Krieger NS, Asplin JR, Cohen-McFarlane M, Culbertson CD, Kyker-Snowman K, Grynpas MD, Bushinsky DA.

Calcif Tissue Int. 2014 May;94(5):531-43. doi: 10.1007/s00223-014-9838-7. Epub 2014 Jan 31.

9.

1,25(OH)ā‚‚Dā‚ƒ-enhanced hypercalciuria in genetic hypercalciuric stone-forming rats fed a low-calcium diet.

Frick KK, Asplin JR, Krieger NS, Culbertson CD, Asplin DM, Bushinsky DA.

Am J Physiol Renal Physiol. 2013 Oct 15;305(8):F1132-8. doi: 10.1152/ajprenal.00296.2013. Epub 2013 Aug 7.

10.

Uromodulin upregulates TRPV5 by impairing caveolin-mediated endocytosis.

Wolf MT, Wu XR, Huang CL.

Kidney Int. 2013 Jul;84(1):130-7. doi: 10.1038/ki.2013.63. Epub 2013 Mar 6.

11.

Increased biological response to 1,25(OH)(2)D(3) in genetic hypercalciuric stone-forming rats.

Frick KK, Asplin JR, Favus MJ, Culbertson C, Krieger NS, Bushinsky DA.

Am J Physiol Renal Physiol. 2013 Mar 15;304(6):F718-26. doi: 10.1152/ajprenal.00645.2012. Epub 2013 Jan 23.

12.

Sex modifies genetic effects on residual variance in urinary calcium excretion in rat (Rattus norvegicus).

Perry GM, Nehrke KW, Bushinsky DA, Reid R, Lewandowski KL, Hueber P, Scheinman SJ.

Genetics. 2012 Jul;191(3):1003-13. doi: 10.1534/genetics.112.138909. Epub 2012 May 2.

13.

Bone disease in primary hypercalciuria.

Sella S, Cattelan C, Realdi G, Giannini S.

Clin Cases Miner Bone Metab. 2008 May;5(2):118-26.

14.

Suppression of intestinal calcium entry channel TRPV6 by OCRL, a lipid phosphatase associated with Lowe syndrome and Dent disease.

Wu G, Zhang W, Na T, Jing H, Wu H, Peng JB.

Am J Physiol Cell Physiol. 2012 May 15;302(10):C1479-91. doi: 10.1152/ajpcell.00277.2011. Epub 2012 Feb 29.

15.

Molecular Pharmacology of Kidney and Inner Ear CLC-K Chloride Channels.

Gradogna A, Pusch M.

Front Pharmacol. 2010 Oct 25;1:130. doi: 10.3389/fphar.2010.00130. eCollection 2010.

16.

Epidemiology of pediatric urolithiasis.

Sharma AP, Filler G.

Indian J Urol. 2010 Oct;26(4):516-22. doi: 10.4103/0970-1591.74450.

17.

High dose vitamin D3 attenuates the hypocalciuric effect of thiazide in hypercalciuric rats.

Jang HR, Lee JW, Kim S, Heo NJ, Lee JH, Kim HS, Jung JY, Oh YK, Na KY, Han JS, Joo KW.

J Korean Med Sci. 2010 Sep;25(9):1305-12. doi: 10.3346/jkms.2010.25.9.1305. Epub 2010 Aug 14.

18.

A regulatory calcium-binding site at the subunit interface of CLC-K kidney chloride channels.

Gradogna A, Babini E, Picollo A, Pusch M.

J Gen Physiol. 2010 Sep;136(3):311-23. doi: 10.1085/jgp.201010455.

19.

Phosphaturia as a promising predictor of recurrent stone formation in patients with urolithiasis.

Ha YS, Tchey DU, Kang HW, Kim YJ, Yun SJ, Lee SC, Kim WJ.

Korean J Urol. 2010 Jan;51(1):54-9. doi: 10.4111/kju.2010.51.1.54. Epub 2010 Jan 21.

20.

The calcium-sensing receptor promotes urinary acidification to prevent nephrolithiasis.

Renkema KY, Velic A, Dijkman HB, Verkaart S, van der Kemp AW, Nowik M, Timmermans K, Doucet A, Wagner CA, Bindels RJ, Hoenderop JG.

J Am Soc Nephrol. 2009 Aug;20(8):1705-13. doi: 10.1681/ASN.2008111195. Epub 2009 May 21.

Supplemental Content

Support Center